FDA Inspection 1016484 — Jean-Philippe Azulay, M.D.
The FDA completed an inspection of Jean-Philippe Azulay, M.D. on May 5, 2017 in Marseille. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 5, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Marseille (France)
Additional Details
Clinical Investigator (CI)